Literature DB >> 15173726

Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery.

Tomomi Hasegawa1, Naoki Yoshimura, Shigeteru Oka, Yoshio Ootaki, Yoshiya Toyoda, Masahiro Yamaguchi.   

Abstract

OBJECTIVES: Perioperative myocardial damage is a major determinant of postoperative cardiac dysfunction for congenital heart disease. Heart fatty acid-binding protein is reported to be a rapid marker of perioperative myocardial damage that peaks earlier than creatine kinase isoenzyme MB or cardiac troponin T in adults. The objective of this study was to assess the suitability of using serum concentrations of heart fatty acid-binding protein for evaluation of perioperative myocardial damage in pediatric cardiac surgery.
METHODS: After institutional review board approval and informed consent, 100 children undergoing open procedures for congenital heart disease were prospectively enrolled in the study. Mean age at operation was 4.9 +/- 0.4 years. Serum concentrations of heart fatty acid-binding protein, creatine kinase isoenzyme MB, and cardiac troponin T were measured serially before operation and at 0, 1, 2, 3, and 6 hours after aortic declamping. Relationships between serum peak level of heart fatty acid-binding protein and intraoperative and postoperative clinical variables were evaluated.
RESULTS: Serum heart fatty acid-binding protein reached its peak level at 1 hour after declamping in 95 patients (95%), which was significantly earlier (P <.01) than serum creatine kinase isoenzyme MB or cardiac troponin T. In addition, serum heart fatty acid-binding protein level immediately after declamping correlated strongly with serum peak heart fatty acid-binding protein level (r = 0.91, P <.01). The serum peak level of heart fatty acid-binding protein correlated with those of creatine kinase isoenzyme MB (r = 0.77, P <.01) and cardiac troponin T (r = 0.80, P <.01). In the forward stepwise multiple regression analysis, age (P <.0001), aortic crossclamp time (P <.0001), the presence of a ventriculotomy (P <.001), and the lowest hematocrit level during cardiopulmonary bypass (P <.05) were significant intraoperative variables that influenced the release of heart fatty acid-binding protein. There were significant relationships between serum peak heart fatty acid-binding protein level and postoperative inotropic support, duration of intubation, and intensive care unit stay (P <.01 for each).
CONCLUSIONS: Heart fatty acid-binding protein is a rapid marker for assessment of myocardial damage and clinical outcome in pediatric cardiac surgery. In particular, serum heart fatty acid-binding protein level immediately after aortic declamping may be a potentially useful prognostic indicator of myocardial damage as well as clinical outcome in pediatric cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173726     DOI: 10.1016/j.jtcvs.2004.02.006

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Amanda A Fox; Charles D Collard; Stanton K Shernan; Simon C Body
Journal:  Anesth Analg       Date:  2010-05-10       Impact factor: 5.108

2.  Elevated preoperative serum asymmetrical dimethylarginine (ADMA) is associated with poor outcomes after pediatric cardiac surgery.

Authors:  Amanda B Hassinger; Mark S Wainwright; Jerome C Lane; Shannon Haymond; Carl L Backer; Eric Wald
Journal:  Intensive Care Med       Date:  2012-08-09       Impact factor: 17.440

3.  Myocardial injury in coronary artery bypass grafting: On-pump versus off-pump comparison by measuring heart-type fatty-acid-binding protein release.

Authors:  Vishwas Malik; Shailaja C Kale; Ujjwal K Chowdhury; Lakshmy Ramakrishnan; Sandeep Chauhan; Usha Kiran
Journal:  Tex Heart Inst J       Date:  2006

4.  Paediatric cardiac surgery in a patient with cold agglutinins.

Authors:  Tomomi Hasegawa; Yoshihiro Oshima; Ayako Maruo; Hironori Matsuhisa
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-18

5.  Effect of dexamethasone on postoperative cardiac troponin T production in pediatric cardiac surgery.

Authors:  Ignacio Malagon; Karin Hogenbirk; Johanes van Pelt; Mark G Hazekamp; James G Bovill
Journal:  Intensive Care Med       Date:  2005-09-16       Impact factor: 17.440

6.  Novel cfDNA Methylation Biomarkers Reveal Delayed Cardiac Cell Death after Open-heart Surgery.

Authors:  Uri Pollak; Hai Zemmour; Elior Shaked; Judith Magenheim; Ori Fridlich; Amit Korach; Alain E Serraf; David Mishaly; Benjamin Glaser; Ruth Shemer; Yuval Dor
Journal:  J Cardiovasc Transl Res       Date:  2022-08-17       Impact factor: 3.216

7.  Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries.

Authors:  Michael G Gaies; Howard E Jeffries; Robert A Niebler; Sara K Pasquali; Janet E Donohue; Sunkyung Yu; Christine Gall; Tom B Rice; Ravi R Thiagarajan
Journal:  Pediatr Crit Care Med       Date:  2014-07       Impact factor: 3.624

8.  Biochemical markers of myocardial injury.

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2007-03

9.  N-terminal pro-B-type natriuretic peptide as a marker of blunt cardiac contusion in trauma.

Authors:  Halil Dogan; Sezgin Sarikaya; Sebnem Tekin Neijmann; Emin Uysal; Neslihan Yucel; Dogac Niyazi Ozucelik; Yıldız Okuturlar; Suleyman Solak; Nurten Sever; Cem Ayan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Cardioplegia in paediatric cardiac surgery: a systematic review of randomized controlled trials.

Authors:  Nigel E Drury; Ivan Yim; Akshay J Patel; Nicola K Oswald; Cher-Rin Chong; John Stickley; Timothy J Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.